3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
4
Triple Negative Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Cancer Patients
1
Pancreatic Neoplasms
1
Locally Advanced Rectal Cancer
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
cabozantinib
2
sodium thiosulfate
1
relacorilant
1
fludarabine phosphate
1
cemiplimab
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Floxuridine
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adrenocortical Carcinoma
×
camrelizumab
×
90 days
×
Clear all
No trials found.